Induction of Influx and Efflux Transporters and Cytochrome P450 3A4 in Primary Human Hepatocytes by Rifampin, Rifabutin, and Rifapentine

被引:113
|
作者
Williamson, Beth [1 ]
Dooley, Kelly E. [2 ,3 ]
Zhang, Yuan [1 ]
Back, David J. [1 ]
Owen, Andrew [1 ]
机构
[1] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England
[2] Johns Hopkins Univ, Sch Med, Dept Med, Div Clin Pharmacol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA
关键词
MULTIDRUG-RESISTANCE PROTEIN-2; CLINICAL PHARMACOKINETICS; TUBERCULOSIS; CELLS; BINDING;
D O I
10.1128/AAC.01124-13
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Rifampin is a potent inducer of cytochrome P450 (CYP) enzymes and transporters. Drug-drug interactions during tuberculosis treatment are common. Induction by rifapentine and rifabutin is understudied. Rifampin and rifabutin significantly induced CYP3A4 (80-fold and 20-fold, respectively) in primary human hepatocytes. The induction was concentration dependent. Rifapentine induced CYP3A4 in hepatocytes from 3 of 6 donors. Data were also generated for ABCB1, ABCC1, ABCC2, organic anion-transporting polypeptide 1B1 (OATP1B1), and OATP1B3. This work serves as a basis for further study of the extent to which rifamycins induce key metabolism and transporter genes.
引用
收藏
页码:6366 / 6369
页数:4
相关论文
共 50 条
  • [41] Potential role for human cytochrome P450 3A4 in estradiol homeostasis
    Yu, AM
    Fukamachi, K
    Krausz, KW
    Cheung, C
    Gonzalez, FJ
    ENDOCRINOLOGY, 2005, 146 (07) : 2911 - 2919
  • [42] Involvement of human cytochrome P450 3A4 in reduced haloperidol oxidation
    Kudo, S
    Odomi, M
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (03) : 253 - 259
  • [43] Thermodynamic landscape of testosterone binding to human cytochrome P450 3A4
    Roberts, AG
    Campbell, AP
    Atkins, WM
    DRUG METABOLISM REVIEWS, 2004, 36 : 69 - 69
  • [44] Expression of human cytochrome p450 3A4 gene in Schizosaccharomyces pombe
    Bedia Palabiyik
    Semian Karaer
    Nazli Arda
    Sidika Erturk Toker
    Guler Temizkan
    Steven Kelly
    Aysegul Topal Sarikaya
    Biologia, 2008, 63 : 450 - 454
  • [45] Involvement of human cytochrome P450 3A4 in reduced haloperidol oxidation
    S. Kudo
    M. Odomi
    European Journal of Clinical Pharmacology, 1998, 54 : 253 - 259
  • [46] The one-electron autoxidation of human cytochrome p450 3A4
    Denisov, Ilia G.
    Grinkova, Yelena V.
    McLean, Mark A.
    Sligar, Stephen G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (37) : 26865 - 26873
  • [47] Chromatographic assays of drug oxidation by human cytochrome P450 3A4
    Sohl, Christal D.
    Cheng, Qian
    Guengerich, F. Peter
    NATURE PROTOCOLS, 2009, 4 (09) : 1252 - 1257
  • [48] Chromatographic assays of drug oxidation by human cytochrome P450 3A4
    Christal D Sohl
    Qian Cheng
    F Peter Guengerich
    Nature Protocols, 2009, 4 : 1252 - 1257
  • [49] Kohonen maps for prediction of binding to human cytochrome P450 3A4
    Balakin, KV
    Ekins, S
    Bugrim, A
    Ivanenkov, YA
    Korolev, D
    Nikolsky, YV
    Skorenko, AV
    Ivashchenko, AA
    Savchuk, NP
    Nikolskaya, T
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (10) : 1183 - 1189
  • [50] Role of human cytochrome p450 3A4 in metabolism of medroxyprogesterone acetate
    Kobayashi, K
    Mimura, N
    Fujii, H
    Minami, H
    Sasaki, Y
    Shimada, N
    Chiba, K
    CLINICAL CANCER RESEARCH, 2000, 6 (08) : 3297 - 3303